Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000078960 | SCV000110825 | benign | not specified | 2014-02-11 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000078960 | SCV000150397 | benign | not specified | 2013-06-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000551589 | SCV000639879 | benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311562 | SCV000846808 | benign | Inborn genetic diseases | 2016-04-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001535388 | SCV001752402 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001535388 | SCV005274735 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000551589 | SCV001452632 | benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2020-09-16 | no assertion criteria provided | clinical testing |